Lorlatinib Versus Pemetrexed-Based Chemotherapy in Patients With ALK-rearranged NSCLC Previously Treated With Alectinib by Takeyasu, Yuki, MD, Yoshida, Tatsuya, XX, Masuda, Ken, XX, Matsumoto, Yuji, XX, Shinno, Yuki, XX, Okuma, Yusuke, XX, Goto, Yasushi, XX, Horinouchi, Hidehito, XX, Yamamoto, Noboru, XX, Ohe, Yuichiro, XX

Get full text